Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best Genomics Stocks to Buy According ...
Regeneron’s first quarter was marked by a negative market reaction, as revenue and non-GAAP earnings...
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behi...
Wealth Enhancement Advisory Services LLC reduced its position in Regeneron Pharmaceuticals, Inc. (NA...